Eli Lilly shares rise after the drugmaker said on Friday that the FDA approved its weight-loss drug Zepbound for moderate-to-severe obstructive sleep apnea in adults with obesity. Xerox shares finish higher after the company struck a $1.5 billion deal to buy printer maker Lexmark. J.R. Whalen reports.
Programming note: Minute Briefing will release its next episode midday Tuesday.
Sign up for the WSJ's free What's News newsletter.
Learn more about your ad choices. Visit megaphone.fm/adchoices